Cargando…
Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo
INTRODUCTION: This study tested the hypothesis that Major Histocompatibility Complex (MHC) incompatible equine mesenchymal stromal cells (MSCs) would induce cytotoxic antibodies to donor MHC antigens in recipient horses after intradermal injection. No studies to date have explored recipient antibody...
Autores principales: | Pezzanite, Lynn M, Fortier, Lisa A, Antczak, Douglas F, Cassano, Jennifer M, Brosnahan, Margaret M, Miller, Donald, Schnabel, Lauren V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414005/ https://www.ncbi.nlm.nih.gov/pubmed/25889095 http://dx.doi.org/10.1186/s13287-015-0053-x |
Ejemplares similares
-
Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro
por: Schnabel, Lauren V, et al.
Publicado: (2014) -
TLR-activated mesenchymal stromal cell therapy and antibiotics to treat multi-drug resistant Staphylococcal septic arthritis in an equine model
por: Pezzanite, Lynn M., et al.
Publicado: (2022) -
Cross‐matching of allogeneic mesenchymal stromal cells eliminates recipient immune targeting
por: Rowland, Aileen L., et al.
Publicado: (2020) -
Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells
por: Berglund, Alix K., et al.
Publicado: (2017) -
Impact of Three Different Serum Sources on Functional Properties of Equine Mesenchymal Stromal Cells
por: Pezzanite, Lynn, et al.
Publicado: (2021)